Cwm LLC decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 58.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 68,551 shares of the healthcare conglomerate’s stock after selling 94,572 shares during the quarter. Cwm LLC’s holdings in UnitedHealth Group were worth $34,959,000 at the end of the most recent reporting period.
Other institutional investors have also made changes to their positions in the company. Signature Estate & Investment Advisors LLC grew its holdings in shares of UnitedHealth Group by 1.2% during the first quarter. Signature Estate & Investment Advisors LLC now owns 1,606 shares of the healthcare conglomerate’s stock worth $820,000 after purchasing an additional 19 shares during the last quarter. Steph & Co. grew its holdings in shares of UnitedHealth Group by 1.6% during the first quarter. Steph & Co. now owns 1,290 shares of the healthcare conglomerate’s stock worth $658,000 after purchasing an additional 20 shares during the last quarter. Palisades Hudson Asset Management LP grew its holdings in shares of UnitedHealth Group by 2.0% during the fourth quarter. Palisades Hudson Asset Management LP now owns 1,078 shares of the healthcare conglomerate’s stock worth $542,000 after purchasing an additional 21 shares during the last quarter. Charter Oak Capital Management LLC grew its holdings in shares of UnitedHealth Group by 2.4% during the fourth quarter. Charter Oak Capital Management LLC now owns 881 shares of the healthcare conglomerate’s stock worth $442,000 after purchasing an additional 21 shares during the last quarter. Finally, Oxford Financial Group Ltd. lifted its stake in shares of UnitedHealth Group by 3.0% in the fourth quarter. Oxford Financial Group Ltd. now owns 720 shares of the healthcare conglomerate’s stock worth $362,000 after acquiring an additional 21 shares during the period. 87.48% of the stock is owned by institutional investors and hedge funds.
A number of equity analysts recently commented on the company. Barclays lifted their price objective on UnitedHealth Group from $495.00 to $565.00 and gave the stock an “overweight” rating in a research note on Wednesday, March 30th. Wells Fargo & Company cut their price objective on UnitedHealth Group from $613.00 to $612.00 and set an “overweight” rating on the stock in a research note on Wednesday, May 25th. SVB Leerink boosted their price target on UnitedHealth Group from $550.00 to $600.00 and gave the company an “outperform” rating in a research note on Tuesday, April 19th. Sanford C. Bernstein lowered UnitedHealth Group from an “outperform” rating to a “market perform” rating and set a $561.00 price target on the stock. in a research note on Thursday, May 26th. They noted that the move was a valuation call. Finally, Royal Bank of Canada set a $563.00 price target on UnitedHealth Group and gave the company an “outperform” rating in a research note on Monday, April 18th. Three analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus target price of $555.73.
Shares of UnitedHealth Group stock opened at $517.40 on Friday. The stock has a fifty day simple moving average of $492.77 and a 200 day simple moving average of $492.61. UnitedHealth Group Incorporated has a 12-month low of $383.12 and a 12-month high of $553.29. The company has a market capitalization of $485.41 billion, a P/E ratio of 28.32, a price-to-earnings-growth ratio of 1.54 and a beta of 0.83. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.54.
UnitedHealth Group (NYSE:UNH – Get Rating) last announced its quarterly earnings data on Thursday, April 14th. The healthcare conglomerate reported $5.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.40 by $0.09. The firm had revenue of $80.15 billion during the quarter, compared to the consensus estimate of $78.77 billion. UnitedHealth Group had a return on equity of 24.74% and a net margin of 5.86%. The business’s revenue for the quarter was up 14.2% on a year-over-year basis. During the same quarter in the previous year, the company earned $5.31 EPS. On average, analysts predict that UnitedHealth Group Incorporated will post 21.75 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 28th. Shareholders of record on Monday, June 20th were paid a $1.65 dividend. This represents a $6.60 dividend on an annualized basis and a yield of 1.28%. The ex-dividend date was Thursday, June 16th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.45. UnitedHealth Group’s dividend payout ratio is 36.12%.
In other news, Director Richard T. Burke sold 2,500 shares of the company’s stock in a transaction on Thursday, May 19th. The stock was sold at an average price of $478.96, for a total transaction of $1,197,400.00. Following the transaction, the director now owns 1,215,000 shares of the company’s stock, valued at approximately $581,936,400. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Erin Mcsweeney sold 1,273 shares of the company’s stock in a transaction on Thursday, June 23rd. The shares were sold at an average price of $499.00, for a total value of $635,227.00. Following the transaction, the executive vice president now directly owns 8,104 shares in the company, valued at approximately $4,043,896. The disclosure for this sale can be found here. Insiders sold a total of 6,273 shares of company stock valued at $3,065,752 in the last 90 days. Corporate insiders own 0.40% of the company’s stock.
UnitedHealth Group Company Profile: (Get Rating)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments. UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children’s health insurance and health care programs; health and dental benefits; and hospital and clinical services.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Get Rating).
Receive News & Ratings for UnitedHealth Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.